期刊文献+

食管癌原发灶PET/CT FDG代谢活性体积与预后相关性的分析 被引量:3

Correlation between FDG PET/CT metabolic activity volume and prognosis in esophageal carcinoma
原文传递
导出
摘要 目的:探讨食管癌原发灶PET/CTFDG代谢活性体积(MAV)与预后的关系。方法:收集可手术的食管鳞癌患者58例,术前行FDG-PET/CT检查,在PET图像上以SUV=2.5扣本底确定原发灶的边界,计算MAV、SUVmax及平均FDG摄取(SUVmean)与最大直径(diameter)的乘积(diameter-SUVindex)。共分为6组,A1组(n=28,MAV≤60),B1组(n=30,MAV>60),A2组(n=32,SUVmax≤8),B2组(n=26,SUVmax>8),A3组(n=35例,diameter-SUV index≤100),B3组(n=23,diameter-SUV index>100)。分别计算各组的1、2、3年生存率,同时进一步对比分析MAV、SUVmax和diameter-SUV index对预后的影响。结果:1、2和3年总生存率,A1组分别为89.3%、82.2%和64.3%,B1组分别为83.3%、70.0%和50.0%,A2组分别为92.8%、82.7%和67.9%,B2组分别为83.3%、69.3%和50.0%,A3组分别为91.5%、85.6%和71.4%,B3组分别为78.3%、60.8%和35.5%,差异均有统计学意义,P值均<0.05。多因素分析显示,di-ameter-SUV index这一指标是预测预后的独立影响因子,较其他两个指标更敏感,P<0.05。结论:食管癌原发灶代谢直径与SUVmean的乘积与患者的生存率密切相关,可评价和预测预后。 OBJECTIVE: To explore the relationship between tumor prognosis and tumor metabolic activity volume measured by 18 F-fluorodeoxyglucose PET/CT in patients with esophageal carci noma. METHODS.. Totally 58 operable patients with esophageal carcinoma were enrolled in this study. All of them had whole body 18 F-fluorodeoxyglucose PET/CT scanned before the operation. We define the boundary of primory tumor with a absolute SUV of 2.5 as segmentation threshold on PET image, and on the basis of this boundary we calculated the MAV. The patients were divided into two groups based the different MAV (Group A1, MAV 460, n= 28; Group B1, MAV〉60, n=30), two groups based the different FDG uptake (SUVmax) of esophageal carcinoma primary lesions (Group A2, SUVmax〉8, n=32; Group B2, SUVmax〉8, n=26), and two groups based on the "diameter-SUV index" which was calculated by multiplying the tumor diameter by the mean SUV (Group A3, diameter-SUV index≤ 100, n = 35 ; Group Ba, diame- ter-SUV index〉100, n=23). RESULTS: The 1-,2-,3-year overall survival rate was 89.3%, 82.2%, 64.3% in the Group A1, while 83.3%,70.0%,50.0% in the Group B1, 92.8%, 82.7%, 67.9% in the Group A2, 83.3%, 69.3%, 50.0% in the Group B2, 91.5%, 85.6%, 71.4% in the Group A3, 78.3%, 60.8%, 35.5% in the Group B3, with statistical difference (P〈0.05). In a Cox regression analysis with inclusion of MAV, SUV diameter-SUV index. The highest accuracy in predicting Prognosis was reached with the diameter-SUV index(P〈0.05). CONCLUSION: The present study shows that the combination of diameter and SUV in the "diameter-SUV index" is valuable for predicting tumor survival and treatment response.
出处 《中华肿瘤防治杂志》 CAS 2011年第15期1186-1188,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 食管肿瘤 原发灶 体层摄影术 脱氧葡萄糖 发射型计算机 预后 esophageal neoplasms primary lesion tomography deoxyglucose position emission prognosis
  • 相关文献

参考文献12

  • 1Kato H. Diagnosis and treatment of esophageal neoplasms[J]. Jpn J Cancer Res, 1995, 86:993-1009.
  • 2Fukuda M, Hirata K, Natori H. Endoscopic ultrasonography of the esophagus[J]. World J Surg,2000, 24: 216-226.
  • 3Menzel J, Hoepffner N, Nottberg H, et al. Preoperative staging of esophageal carcinoma: Miniprohe sonography versus conventional endscopic ultrasound in a prospective histopathologically verified study[J]. Endoscopy,1999, 31:291-297.
  • 4Johannes BR, Elkan FH, Rivka RC, et al. Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus[J]. Mol Imaging Biol, 2009,11(1):54-60.
  • 5Yuan S, Yu J, Chao K S, et al. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer[J]. J Nucl Med, 2006, 47(8):1255-1259.
  • 6史文杰,王滨,李思源,齐荣义,石涛.PET-CT诊断肺癌并全身多发囊性转移瘤[J].华北国防医药,2009,21(6):33-34. 被引量:4
  • 7巩合义,于金明.PET乏氧显像预测肿瘤疗效研究进展[J].中华核医学杂志,2005,25(1):57-58. 被引量:12
  • 8孙海辉,王家强,乔智红,邱书王君.PET和PET/CT在食管癌中的临床应用价值[J].山东医药,2010,50(7):112-113. 被引量:3
  • 9Johnson CR, Thames HD, Huang DT, et al. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography[J]. Int J Radiat Oncol Biol Phys, 1995,33: 281-287.
  • 10向作林,曾昭冲,吴铮,管一晖.头颈部肿瘤^18F-FDG PET/CT诊断价值的探讨[J].中华肿瘤防治杂志,2009,16(6):457-459. 被引量:3

二级参考文献56

共引文献27

同被引文献28

  • 1黄志刚,范增林,李学民,王世合,杨新生,张云杰,暴志芹.971例食管癌切除术后患者预后的Cox回归分析[J].实用肿瘤杂志,2005,20(3):263-266. 被引量:15
  • 2赵卫,任宏政,陈奎生,陈芙蓉,张振,王磊.食管癌组织中GLUT_1和HIF-1α蛋白表达与癌细胞浸润转移及预后的研究[J].肿瘤基础与临床,2007,20(1):18-20. 被引量:5
  • 3Bm'ba M, Sperati F, Stranges S, et al. Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents:results from a historic cohort [ J 1. Ann Oncol,2012,23 (7) : 1838 - 1845.
  • 4Luo J, Chen YJ, Chang LJ. Fasting blood glucose level and prognosis in non-small cell lung cancer ( NSCLC ) patients [ J ]. Lung Cancer,2012,76(2) :242-247.
  • 5Parekh N, Lin Y, Hayes RB, et al. Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey[ J. Cancer Causes Control,2010,21 (4) :631 -642.
  • 6Warburg 0. On the origin of cancer cells[ J]. Science, 1956,123 (3191) :309 -314.
  • 7Wood KA,Hoskin PJ,Saunders MI. Positron emission to- mography in oncology:a review [J]. Clin Oncol(R Coil Radi- ol) ,2007,19(4) :237-255.
  • 8Kostakoglu L, Goldsmith SJ. 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast,lung,and eoloreetal carcinoma[ J ]. J Nuel Med, 2003,44 ( 2 ) : 224-239.
  • 9Atsumi K, Nakamura K, Abe KA, et al. Predietion of outcome with FDG-PET in definitive chemoradiotherapy for esophag- eal cancer[ J ]. J Radiat Res, 2013,54( 5 ) : 890-898.
  • 10Cooper JS,Guo MD,Herskovic A,et al. Chemoradiotherapy of locally advanced esophageal cancer) :long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group [ J ]. JAMA, 1999,281 ( 17 ) : 1623 - 1627.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部